mGlu5, Dopamine D(2) and Adenosine A(2A) Receptors in L-DOPA-induced Dyskinesias

Patients with Parkinson’s disease (PD) receiving L-3,4-dihydroxyphenylalanine (L-DOPA, the gold-standard treatment for this disease) frequently develop abnormal involuntary movements, termed L-DOPA-induced dyskinesias (LID). Glutamate overactivity is well documented in PD and LID. An approach to man...

Descripción completa

Detalles Bibliográficos
Autores principales: Morin, Nicolas, Morissette, Marc, Grégoire, Laurent, Di Paolo, Thérèse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983750/
https://www.ncbi.nlm.nih.gov/pubmed/26639458
http://dx.doi.org/10.2174/1570159X14666151201185652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983750/
https://www.ncbi.nlm.nih.gov/pubmed/26639458
http://dx.doi.org/10.2174/1570159X14666151201185652

Ejemplares similares